SCHEDULE OF GOODWILL (Details) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Impairment Effects on Earnings Per Share [Line Items] | ||
| Balance | $ 26,689,391 | $ 32,836,563 |
| Additions | 32,977,908 | |
| Purchase consideration adjustments | (9,512,380) | |
| Impairment | (14,327,871) | (29,612,700) |
| Balance | 12,361,520 | 26,689,391 |
| Starco Brands [Member] | ||
| Impairment Effects on Earnings Per Share [Line Items] | ||
| Balance | 2,944,871 | 12,089,871 |
| Additions | ||
| Purchase consideration adjustments | ||
| Impairment | (2,944,871) | (9,145,000) |
| Balance | 2,944,871 | |
| Skylar [Member] | ||
| Impairment Effects on Earnings Per Share [Line Items] | ||
| Balance | 11,234,312 | 20,746,692 |
| Additions | ||
| Purchase consideration adjustments | (9,512,380) | |
| Impairment | ||
| Balance | 11,234,312 | 11,234,312 |
| Soylent [Member] | ||
| Impairment Effects on Earnings Per Share [Line Items] | ||
| Balance | 12,510,208 | |
| Additions | 32,977,908 | |
| Purchase consideration adjustments | ||
| Impairment | (11,383,000) | (20,467,700) |
| Balance | $ 1,127,208 | $ 12,510,208 |
| X | ||||||||||
- Definition Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) from measurement period adjustment of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|